Akari Therapeutics is an oncology biotechnology company developing next-generation antibody drug conjugates (ADCs) with a unique payload, PH1, which targets RNA splicing. Utilizing its innovative ADC ...
The best hybrid bikes offer a balance of performance and comfort, seeing you through everything from the weekly commute to ...
Akari Therapeutics, Plc (Nasdaq: AKTX), an oncology biotechnology company developing antibody drug conjugates (ADCs) with novel RNA splice modulating ...
Background Alcohol use disorder and treatment-resistant depression (TRD) often co-occur, presenting a major clinical challenge with limited effective treatments. However, ketamine produces rapid ...
Morning Overview on MSN
Study finds cancer drugs can pool in tumor cell hubs, fueling resistance
Cancer drugs like cisplatin are designed to attack tumor cells, but new research shows these therapies can concentrate inside specialized molecular clusters within the nucleus, altering how ...
A team of researchers co-led by the University of California San Diego, University of Michigan, and the French National ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results